Open AccessEnhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil–containing Immunosuppressive Regimens
Author(s) -
Silke E de Boer,
Stefan P. Berger,
Coretta C. van Leer-Buter,
BartJan Kroesen,
Debbie van Baarle,
Jan-Stephan Sanders
Publication year - 2022
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000004177
Subject(s) - medicine , everolimus , mycophenolate , regimen , mycophenolic acid , population , kidney transplantation , prednisolone , calcineurin , vaccination , immunology , transplantation , environmental health
Elderly kidney transplant recipients (KTRs) represent almost one third of the total kidney transplant population. These patients have a very high coronavirus disease 2019 (COVID-19)-related mortality, whereas their response to COVID-19 vaccination is impaired. Finding ways to improve the COVID-19 vaccination response in this vulnerable population is of uttermost importance.